Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trial

Menezes, DL; See, WL; Risueño, A; Tsai, KT; Lee, JK; Ma, J; Khan, R; Prebet, T; Skikne, B; Beach, CL; Thakurta, A; Gandhi, A

Menezes, DL (通讯作者)，Bristol Myers Squibb, 1500 Owens St,Suite 600, San Francisco, CA 94158 USA.

BRITISH JOURNAL OF HAEMATOLOGY, 2023; 201 (6): 1129

Abstract

Oral azacitidine (Oral-AZA) maintenance therapy improved relapse-free (RFS) and overall survival (OS) significantly versus placebo for AML patients in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索